Infliximab Concentrations during Induction Are Predictive for Endoscopic Remission in Pediatric Patients with Inflammatory Bowel Disease under Combination Therapy-Reference-Cited by-同舟云学术

Infliximab Concentrations during Induction Are Predictive for Endoscopic Remission in Pediatric Patients with Inflammatory Bowel Disease under Combination Therapy

Published:2022-01 Issue: Volume:240 Page:150-157.e4
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

van Hoeve Karen,Seyed Tabib Nasim Sadat,Dreesen Erwin,Tops Sophie,Hoffman Ilse,Gils Ann^ORCID,Ferrante Marc^ORCID,Vermeire Séverine

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology and Child Health

Reference41 articles.

1. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease;Ruemmele;J Crohns Colitis,2014

2. Management of paediatric ulcerative colitis, part 1: ambulatory care-an evidence-based guideline from European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition;Turner;J Pediatr Gastroenterol Nutr,2018

3. Novel targeted therapies for inflammatory bowel disease;Coskun;Trends Pharmacol Sci,2017

4. Ustekinumab as induction and maintenance therapy for Crohn's disease;Feagan;N Engl J Med,2016

5. Vedolizumab as induction and maintenance therapy for ulcerative colitis;Feagan;N Engl J Med,2013

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Forecasted infliximab concentrations during induction predict time to remission and sustained disease control of inflammatory bowel disease;Clinics and Research in Hepatology and Gastroenterology;2024-06

2. Crohn’s Patient Serum Proteomics Reveals Response Signature for Infliximab but not Vedolizumab;Inflammatory Bowel Diseases;2024-02-17

3. Early infliximab trough levels in paediatric IBD patients predict sustained remission;Therapeutic Advances in Gastroenterology;2023-12-30

4. Identifying risk factors of anti‐TNF induced skin lesions and other adverse events in paediatric patients with inflammatory bowel disease;Journal of Pediatric Gastroenterology and Nutrition;2023-12-10

5. Precision Dosing of Anti-TNF Therapy in Pediatric Inflammatory Bowel Disease;Current Gastroenterology Reports;2023-09-11